The lncRNA NORAD facilitates cancer development, whose expression is upregulated and associated with poor prognosis in several cancers, including bladder, squamous cell, breast, colorectal, esophageal, and pancreatic cancers (Li et al., 2017; Li et al., 2018; Tan et al., 2019; Zhou et al., 2019; Aprile et al., 2020a; Soghli et al., 2021). Here, NORAD is linked to cancer.